Skip to main content
HAXC Holdings (Beijing) Co., Ltd. logo

HAXC Holdings (Beijing) Co., Ltd. — Investor Relations & Filings

Ticker · 300928 ISIN · CNE100004B46 Shenzhen Stock Exchange Financial and insurance activities
Filings indexed 633 across all filing types
Latest filing 2026-05-18 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300928

About HAXC Holdings (Beijing) Co., Ltd.

https://www.haxc.com.cn

HAXC Holdings (Beijing) Co., Ltd. is a diversified investment holding group focused on biotechnology, cultural sports, and real estate development. The company is recognized for its significant presence in the biotechnology sector, particularly through its involvement in the production and distribution of hyaluronic acid and other bioactive substances for global pharmaceutical, cosmetic, and food industries. HAXC Holdings also manages large-scale cultural and commercial complexes under the 'Huaxi LIVE' brand, integrating sports, entertainment, and lifestyle services. The group emphasizes technological innovation and the development of high-end medical aesthetic products and consumer skincare brands. Its operations span the entire value chain from research and development to manufacturing and retail, catering to both industrial clients and end consumers worldwide.

Recent filings

Filing Released Lang Actions
关于持股5%以上股东部分股份解除质押的公告
Regulatory Filings Classification · 85% confidence The document is a formal announcement by the company’s board disclosing that a >5% shareholder (Mr. Xiao) has released (“解除质押”) part of his pledged shares. It contains tables of pledge/unpledge details and no financial statements or results. It is neither a securities issuance, share repurchase, nor an insider purchase/sale, nor a dividend or threshold-crossing shareholding change. This fits best as a general regulatory announcement (fallback category).
2026-05-18 Chinese
北京植德律师事务所关于华安鑫创控股(北京)股份有限公司2025年年度股东会的法律意见书
Regulatory Filings Classification · 80% confidence The document is a legal opinion letter (‘法律意见书’) issued by MeritsTree law firm regarding the legality of the convening, procedures, participants’ qualifications, and voting results of Hua’an Xinchuang’s 2025 annual shareholders’ meeting. It is not the annual report itself, nor a financial disclosure, proxy statement, or AGM presentation. It does include detailed voting results, but as a compliance/legal opinion rather than a straight vote announcement. Therefore it best fits the general Regulatory Filings category (RNS) as a compliance/legal document.
2026-05-15 Chinese
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is the official announcement of the 2025 annual shareholders’ meeting resolutions, detailing meeting attendance, each proposal, and voting results. It is not the full annual report or proxy materials but a declaration of the voting outcomes at the AGM. This matches the “Declaration of Voting Results & Voting Rights Announcements” category.
2026-05-15 Chinese
关于持股5%以上股东部分股份质押的公告
Major Shareholding Notification Classification · 75% confidence The document is a regulatory announcement by a listed company disclosing that a shareholder holding over 5% of its shares has pledged part of their stake. There is no transfer of company shares, no buyback, and no financial report or voting matter. This fits as a major shareholding notification concerning changes in significant shareholder status (share pledge). Thus, the best match is Major Shareholding Notification (MRQ).
2026-05-11 Chinese
国金证券股份有限公司关于华安鑫创控股(北京)股份有限公司2025年度募集资金存放与使用情况的专项核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed special audit opinion report by the sponsoring institution (Guojin Securities Co., Ltd.) on the storage and use of raised funds by Hua'an Xincheng Holdings (Beijing) Co., Ltd. for the fiscal year 2025. It includes extensive financial data on fundraising, usage, changes in investment projects, compliance with regulatory requirements, and detailed tables on fund usage and project changes. The document references regulatory rules related to fundraising and stock issuance, and it is a specialized audit on the use of raised funds rather than a full annual or interim financial report. It is not a simple announcement or certification but a substantive audit report on fundraising usage. Therefore, it fits the category of Audit Report / Information (AR).
2026-04-23 Chinese
2025年度独立董事述职报告(第三届独董解占军)
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Annual Report" for the year 2025 by 解占军, an independent director of 华安鑫创控股(北京)股份有限公司. It details the director's duties, attendance at board and committee meetings, communication with auditors, oversight of company governance, and specific matters such as related party transactions, internal control reports, appointment of senior management, and compliance with laws and regulations. The document is a detailed narrative of the independent director's activities and oversight during the year, which is a form of management or board information rather than a full financial report or audit report. It is not an announcement or a brief summary but a substantive report on governance and director duties. Therefore, it fits best under Board/Management Information (MANG). The document length is 4382 characters, which is substantive but not a full annual report or audit report. No financial statements or audit opinions are included, so it is not 10-K or AR. It is not a call transcript, capital update, or other categories. Hence, the classification is MANG with high confidence.
2026-04-23 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.